Investors

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

2020 – 2022

2021

Annual Report 2021 (English version)

2020

Calendar and upcoming reports

February 22, 2023
Year-end Report Q4 2022

March 14, 2023
Carnegie Healthcare Seminar (Stockholm)

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com